Efficacy and Safety of the Biosimilar Recombinant Human Parathyroid Hormone Cinnopar® in Postmenopausal Osteoporotic Women: A Randomized Double-blind Clinical Trial

Efficacy and Safety of the Biosimilar Recombinant Human Parathyroid Hormone Cinnopar® in Postmenopausal Osteoporotic Women: A Randomized Double-blind Clinical Trial

Background: Due to high cost and burden of osteoporosis, it is reasonable to focus on the reduction of fractures as the main goal of treatment. We compared the efficacy and safety of a new biosimilar recombinant human parathyroid hormone (CinnoPar®, CinnaGen, Iran) to the reference product (Forteo®,...

Full description

Saved in:
Bibliographic Details
Main Authors: Ozra TABATABAEI-MALAZY (Author), Masumeh NORANI (Author), Ramin HESHMAT (Author), Mostafa QORBANI (Author), Afsaneh VOSOOGH (Author), Behnaz AFRASHTEH (Author), Farzin KAHKESHAN (Author), Arman AJAMI (Author), Bagher LARIJANI (Author)
Format: Book
Published: Tehran University of Medical Sciences, 2018-08-01T00:00:00Z.
Subjects:
article
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

Connect to this object online.

3rd Floor Main Library

Holdings details from 3rd Floor Main Library
Call Number: A1234.567
Copy 1 Available

Similar Items